Back to results
US 2026/0062732 A1Published application
Test method for mild cognitive impairment, test reagent for mild cognitive impairment, and method for screening therapeutic candidate substances for mild cognitive impairment
AssigneeBioradical Research Institute Corp.
InventorsMasaichi Lee, Tomoko Komatsu
Life of this patent
Estimating the term…
Abstract
Provided is a test method with which mild cognitive impairment (MCI) is detectable and a measurement reagent for use in the test method. A test method for MCI according to the present invention includes a step of measuring the activity of superoxide dismutase (SOD) in a biological sample of a subject.
Claims7
1-13. (canceled)
A method for detecting activity of SOD in a subject who is a suspected case of MCI, the method comprising:
- a step of detecting SOD activity in a biological sample of the subject using a reagent for measuring the SOD activity.
Dependencies are inferred from the claim text.